ATC level 4
L04ACImmunosuppressive drug, subgroup L04AC
- Molecules
- 20
- Subgroups
- 17
ATC L04AC (Immunosuppressive drug, subgroup L04AC) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 20 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
- L04AC02Basiliximab1
- L04AC03Anakinra1
- L04AC04Rilonacept1
- L04AC05Ustekinumab1
- L04AC06Mepolizumab1
- L04AC07Tocilizumab1
- L04AC08Canakinumab2
- L04AC10Secukinumab1
- L04AC11Siltuximab1
- L04AC12Brodalumab1
- L04AC13Ixekizumab1
- L04AC14Sarilumab1
- L04AC16Guselkumab1
- L04AC17Tildrakizumab1
- L04AC18Risankizumab1
- L04AC22Spesolimab1
- L04AC28Icotrokinra1
Molecules
Molecules with an ATC code under L04AC.
- AnakinraOrphanInterleukin-1 Receptor Antagonist1 presentation1 brandL04AC03
- BasiliximabOrphanInterleukin-2 Receptor Blocking Antibody1 presentation2 brandsL04AC02
- BimekizumabBiologic2 presentations2 brandsL04AC
- BrodalumabBiologicAntibodies1 presentation2 brandsL04AC12
- CanakinumabOrphan1 presentation2 brandsL04AC08
- GuselkumabBiologicInterleukin-23 Antagonist3 presentations2 brandsL04AC16
- Icotrokinra1 presentation2 brandsL04AC28
- IxekizumabBiologicInterleukin-17A Antagonist3 presentations2 brandsL04AC13
- MepolizumabOrphanInterleukin-5 Antagonist3 presentations2 brandsL04AC06
- MirikizumabOrphanInterleukin-23 Antagonist4 presentations2 brandsL04AC
- RilonaceptOrphan1 presentation1 brandL04AC04
- RisankizumabOrphanInterleukin-23 Antagonist6 presentations2 brandsL04AC18
- SarilumabBiologicInterleukin-6 Receptor Antagonist2 presentations2 brandsL04AC14
- SatralizumabOrphan2 presentations2 brandsL04AC
- SecukinumabBiologicInterleukin-17A Antagonist4 presentations2 brandsL04AC10
- SiltuximabOrphanInterleukin-6 Antagonist2 presentations2 brandsL04AC11
- SpesolimabOrphanInterleukin-36 Receptor Antagonist6 presentations3 brandsL04AC22
- TildrakizumabBiologicInterleukin-23 Antagonist2 presentations2 brandsL04AC17
- TocilizumabOrphanInterleukin-6 Receptor Antagonist17 presentations10 brandsL04AC07
- UstekinumabOrphanInterleukin-12 Antagonist32 presentations23 brandsL04AC05
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.